Insider · CIK 0001254705
Garen G Bohlin
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC), KPTI (Karyopharm Therapeutics Inc.). First filing May 13, 2026, latest May 13, 2026.
Garen G Bohlin files SEC Form 4 as director at COLL (COLLEGIUM PHARMACEUTICAL, INC), and also at KPTI (Karyopharm Therapeutics Inc.). Since May 13, 2026, Garen G Bohlin has reported 0 open-market buys worth $0 and 1 open-market sell worth $323k, the latest filed on May 13, 2026.
A track record needs three past buys with six months of prices behind them; Garen G Bohlin has 0, so none is measured yet.
The newest scored trade: sold $323k of COLL on May 11, 2026, filed May 13, 2026, scored 34 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $323k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | COLLEGIUM PHARMACEUTICAL, INC | $323k 8,700 shares | -12% | +24% from low-28% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +15,508 | $0.00 | $0 | 18,517 | May 26, 2026 |
| May 14, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +8,741 | $0.00 | $0 | 71,000 | May 18, 2026 |
| May 11, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock | +8,700 | $16.49 | $143k | 70,959 | May 13, 2026 |
| May 11, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock | -8,700 | $37.18 | $323k | 62,259 | May 13, 2026 |
| May 11, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative | -8,700 | $0.00 | $0 | 0 | May 13, 2026 |
| May 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +4,600 | $0.00 | $0 | 4,600 | May 29, 2025 |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +9,791 | $0.00 | $0 | 62,259 | May 19, 2025 |
Questions about Garen G Bohlin
Answered from the filings on this page, as of the latest one.
Is Garen G Bohlin buying or selling?
In the last 12 months Garen G Bohlin reported 0 open-market buys worth $0 and 1 open-market sell worth $323k on SEC Form 4; the latest was sold $323k of COLL on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Garen G Bohlin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Garen G Bohlin has 0.
Where does Garen G Bohlin file Form 4?
Garen G Bohlin has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC); KPTI (Karyopharm Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.